Andrea Kühn, MD, PhD, Charité – University Medicine Berlin, Berlin, Germany, gives an overview of new developments in deep brain stimulation (DBS) to be discussed at the MDS 2021 virtual congress. A major area of excitement is the use of lesion network mapping to maximize the efficacy of DBS and minimize side effects. Prof. Kühn describes ongoing work to develop connectomic-based neuromodulation that can target specific networks to modulate abnormal activity. This interview took place during the 2021 International Congress of Parkinson’s Disease and Movement Disorders.
Prof. Kühn reports the following disclosures:
Honoraria for lectures and consultancies: Medtronic and Boston Scientific
Advisory Board: Medtronic